Cambridge Investment Research Advisors, Inc. Neuroone Medical Technologies Corp Transaction History
Cambridge Investment Research Advisors, Inc.
- $36.4 Billion
- Q3 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Neuroone Medical Technologies Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 121,000 shares of NMTC stock, worth $83,490. This represents 0.0% of its overall portfolio holdings.
Number of Shares
121,000
Previous 81,000
49.38%
Holding current value
$83,490
Previous $55,000
96.36%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NMTC
# of Institutions
37Shares Held
14.4MCall Options Held
65.2KPut Options Held
0-
Bleichroeder LP New York, NY4MShares$2.76 Million0.95% of portfolio
-
Sio Capital Management, LLC New York, NY2.36MShares$1.63 Million0.73% of portfolio
-
Bard Associates Inc Chicago, IL1.85MShares$1.28 Million0.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.58MShares$1.09 Million0.0% of portfolio
-
Perkins Capital Management Inc1.47MShares$1.01 Million1.29% of portfolio
About NEUROONE MEDICAL TECHNOLOGIES Corp
- Ticker NMTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,209,200
- Market Cap $11.2M
- Description
- NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for pat...